-
1
-
-
0034117209
-
Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries - Are there differences from developed countries?
-
Arendorf T, Holmes H: Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries-are there differences from developed countries? Oral Dis 2000; 6:133-135. (Pubitemid 30344983)
-
(2000)
Oral Diseases
, vol.6
, Issue.3
, pp. 133-135
-
-
Arendorf, T.1
Holmes, H.2
-
3
-
-
63849233258
-
The changing face of epidemiology of invasive fungal disease in Europe
-
Lass-Florl C: The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 19 7-2 0 5.
-
(2009)
Mycoses
, vol.52
, pp. 197-205
-
-
Lass-Florl, C.1
-
4
-
-
67650723105
-
Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: A review of the literature (2005-2009)
-
Espinel-Ingroff A: Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009). Rev Iberoam Mi-col 2009; 26: 15-2 2.
-
(2009)
Rev Iberoam Mi-col
, vol.26
, pp. 15-22
-
-
Espinel-Ingroff, A.1
-
5
-
-
0002277869
-
Invasive fungal infections: Problem and challenges for developing new anti-fungal compounds; In
-
Ssutcliffe J, Gergopa-padakou NH (eds) N.Y., Chapman and Hall
-
Walsh TJ: Invasive fungal infections: problem and challenges for developing new anti-fungal compounds; in Ssutcliffe J, Gergopa-padakou NH (eds): Emerging Targets in Antibacterial and Antifungal Chemotherapy. N.Y., Chapman and Hall, 1992, pp 349-373.
-
(1992)
Emerging Targets in Antibacterial and Antifungal Chemotherapy.
, pp. 349-373
-
-
Walsh, T.J.1
-
6
-
-
33846466508
-
Epidemiology of invasive candidiasis: A persistent public health problem
-
DOI 10.1128/CMR.00029-06
-
Pfaller MA, Diekema DJ: Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163. (Pubitemid 46167771)
-
(2007)
Clinical Microbiology Reviews
, vol.20
, Issue.1
, pp. 133-163
-
-
Pfaller, M.A.1
Diekema, D.J.2
-
7
-
-
4644248400
-
Development and characterization of an in vivo central venous catheter candida albicans biofilm model
-
A nde s D, Ne t t J, Oschel P, A lb er t R, Ma rchi l-lo K, Pitula A: Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Im-mun 2004; 72:6023-6031.
-
(2004)
Infect Im-mun
, vol.72
, pp. 6023-6031
-
-
Andes, D.1
Nett, J.2
Oschel, P.3
Albert, R.4
Marchil-Lo, K.5
Pitula, A.6
-
8
-
-
71249123989
-
Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs
-
Swoboda S, Lichtenstern C, Ober MC, Taylor LA, Störzinger D, Michel A, et al: Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs. Chemotherapy 2009; 55:418-424.
-
(2009)
Chemotherapy
, vol.55
, pp. 418-424
-
-
Swoboda, S.1
Lichtenstern, C.2
Ober, M.C.3
Taylor, L.A.4
Störzinger, D.5
Michel, A.6
-
9
-
-
70350026151
-
Antifun-gal drug resistance mechanisms in fungal pathogens from the perspective of transcrip-tional gene regulation
-
Sanglard D, Coste A, Ferrari S: Antifun-gal drug resistance mechanisms in fungal pathogens from the perspective of transcrip-tional gene regulation. FEMS Yeast Res 2009; 9: 1029-105 0.
-
(2009)
FEMS Yeast Res
, vol.9
, pp. 1029-1050
-
-
Sanglard, D.1
Coste, A.2
Ferrari, S.3
-
10
-
-
33748933537
-
Current status of antifungal therapy for systemic mycoses
-
Nosanchuk JD: Current status of antifungal therapy for systemic mycoses. Recent Pat Antiinfect Drug Discov 20 06; 1: 75-84.
-
(2006)
Recent Pat Antiinfect Drug Discov
, vol.1
, pp. 75-84
-
-
Nosanchuk, J.D.1
-
11
-
-
0142134314
-
Antifungal agents: Their diversity and increasing sophistication
-
DOI 10.1017/S0269915X03002064
-
Odds FC: Antifungal agents: their diversity and increasing sophistication. Mycologist 2003; 17: 51-5 5. (Pubitemid 37292991)
-
(2003)
Mycologist
, vol.17
, Issue.2
, pp. 51-55
-
-
Odds, F.C.1
-
12
-
-
66449112829
-
Efflux-mediated antifungal drug resistance
-
Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, et al: Efflux-mediated antifungal drug resistance. Clin Micro-biol Rev 2009; 22:291-321.
-
(2009)
Clin Micro-biol Rev
, vol.22
, pp. 291-321
-
-
Cannon, R.D.1
Lamping, E.2
Holmes, A.R.3
Niimi, K.4
Baret, P.V.5
Keniya, M.V.6
-
13
-
-
34548429972
-
Pathogenicity and drug resistance in Candida albicans and other yeast species
-
DOI 10.1556/AMicr.54.2007.3.1
-
Mishra NN, Prasad T, Sharma N, Payasi A, Prasad R, Gupta DK, et al: Pathogenicity and drugresistance in Candida albicans and other yeast species. Acta Microbiol Immunol Hung 2007; 54:201-235. (Pubitemid 47364462)
-
(2007)
Acta Microbiologica et Immunologica Hungarica
, vol.54
, Issue.3
, pp. 201-235
-
-
Mishra, N.N.1
Prasad, T.2
Sharma, N.3
Payasi, A.4
Prasad, R.5
Gupta, D.K.6
Singh, R.7
-
14
-
-
18044375585
-
Candida biofilms: An update
-
DOI 10.1128/EC.4.4.633-638.2005
-
Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL: Candida biofilms: an update. Eu-karyot Cell 2005; 4:633-638. (Pubitemid 40600417)
-
(2005)
Eukaryotic Cell
, vol.4
, Issue.4
, pp. 633-638
-
-
Ramage, G.1
Saville, S.P.2
Thomas, D.P.3
Lopez-Ribot, J.L.4
-
16
-
-
50449104506
-
Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi
-
Borelli C, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, et al: Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy 2008; 54:245-259.
-
(2008)
Chemotherapy
, vol.54
, pp. 245-259
-
-
Borelli, C.1
Schaller, M.2
Niewerth, M.3
Nocker, K.4
Baasner, B.5
Berg, D.6
-
17
-
-
66749184717
-
Microtubules and actin cytoskeletons of potentially pathogenic basidiomycetous yeast as targets for antifun-gals
-
Kopecká M, Gabriel M: Microtubules and actin cytoskeletons of potentially pathogenic basidiomycetous yeast as targets for antifun-gals. Chemotherapy 2009; 55:278-286.
-
(2009)
Chemotherapy
, vol.55
, pp. 278-286
-
-
Kopecká, M.1
Gabriel, M.2
-
18
-
-
0032823635
-
Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action
-
Cardenas ME, Cruz MC, Del Poeta M, Chung N, Perfect JR, Heitman J: Antifungal activities of antineoplastic agents: Saccharo-myces cerevisiae as a model system to study drug action. Clin Microbiol Rev 1999; 12: 583-611. (Pubitemid 29484748)
-
(1999)
Clinical Microbiology Reviews
, vol.12
, Issue.4
, pp. 583-611
-
-
Cardenas, M.E.1
Cruz, M.C.2
Del Poeta, M.3
Chung, N.4
Perfect, J.R.5
Heitman, J.6
-
19
-
-
76749134217
-
Antica ncer agents aga inst malaria: Time to revisit?
-
Nzila A, Okombo J, Becker RP, Chilengi R, Lang T, Niehues T: Antica ncer agents aga inst malaria: time to revisit? Trends Parasitol 2010; 26: 125-129.
-
(2010)
Trends Parasitol
, vol.26
, pp. 125-129
-
-
Nzila, A.1
Okombo, J.2
Becker, R.P.3
Chilengi, R.4
Lang, T.5
Niehues, T.6
-
20
-
-
2342509759
-
Dual purpose: Some cancer therapies used to treat autoimmune diseases
-
Ben-Ari ET: Dual purpose: some cancer therapies used to treat autoimmune diseases. J Natl Ca ncer Inst 2004; 96: 577-579. (Pubitemid 38584977)
-
(2004)
Journal of the National Cancer Institute
, vol.96
, Issue.8
, pp. 577-579
-
-
Ben-Ari, E.T.1
-
21
-
-
0025164671
-
Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth
-
Ghannoum MA, Abu-Elteen KH, Motaway MS, Abu-Hatab MA, Ibrahim AS, Criddle RS: Combinations of antifungal and anti-neoplastic drugs with interactive effects on inhibition of yeast growth. Chemotherapy 1990; 36:308-320. (Pubitemid 20251913)
-
(1990)
Chemotherapy
, vol.36
, Issue.4
, pp. 308-320
-
-
Ghannoum, M.A.1
Abu-Elteen, K.H.2
Motawy, M3
S.4
Abu-Hatab, M.A.5
Ibrahim, A.S.6
Criddle, R.S.7
-
22
-
-
0024557291
-
Interactive effects of antifungal and antineoplastic agents on yeasts commonly prevalent in cancer patients
-
Ghannoum MA, Motaway MS, Abu-Hatab MA, Abu-Elteen KH, Criddle RS: Interactive effect of antifungal and antineoplastic agents on yeasts commonly prevalent in cancer patients. Antimicrob Agents Chemother 1989; 33:726-730. (Pubitemid 19120020)
-
(1989)
Antimicrobial Agents and Chemotherapy
, vol.33
, Issue.5
, pp. 726-730
-
-
Ghannoum, M.A.1
Motawy, M.S.2
Abu Hatab, M.A.3
Abu Elteen, K.H.4
Criddle, R.S.5
-
23
-
-
26844437212
-
Morphological and growth altering effects of cisplatin in c. Albicans using fluorescence microscopy
-
Kesavan C, Raghunathan M, Ganesan N: Morphological and growth altering effects of cisplatin in C. albicans using fluorescence microscopy. Ann Clin Microbiol Antimi-crob 2005; 4:1-4.
-
(2005)
Ann Clin Microbiol Antimi-crob
, vol.4
, pp. 1-4
-
-
Kesavan, C.1
Raghunathan, M.2
Ganesan, N.3
-
24
-
-
30744433912
-
5-Fluorouracil altered morphology and inhibited growth of Candida albicans [3]
-
DOI 10.1128/JCM.43.12.6215-6216.2005
-
Kesavan C, Joyee AG: 5-Fluorouracil altered morphology and inhibited growth of C. albi-cans. J Clin Microbiol 2005; 43: 6215-6216. (Pubitemid 43100698)
-
(2005)
Journal of Clinical Microbiology
, vol.43
, Issue.12
, pp. 6215-6216
-
-
Kesavan, C.1
Joyce, A.G.2
-
25
-
-
67749091065
-
Antifungal activity of tamoxifen: In vitro and in vivo activities and mechanistic characterization
-
Dola n K, Montgomer y S, Buchheit B, Didone L, Wellington M, Krysan D: Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization. Antimicrob Agents Chemother 2009; 53: 3337-3346.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3337-3346
-
-
Dolan, K.1
Montgomery, S.2
Buchheit, B.3
Didone, L.4
Wellington, M.5
Krysan, D.6
-
26
-
-
18544390708
-
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases
-
DOI 10.1128/JCM.43.5.2155-2162.2005
-
Richter SS, Galask R P, Diekema DJ, Messer SA, Pfaller MA, Hollis RJ: Antifungal susceptibilities of Candida species causing vul-vovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005; 43:2155-2162. (Pubitemid 40656220)
-
(2005)
Journal of Clinical Microbiology
, vol.43
, Issue.5
, pp. 2155-2162
-
-
Richter, S.S.1
Galask, R.P.2
Messer, S.A.3
Hollis, R.J.4
Diekema, D.J.5
Pfaller, M.A.6
-
27
-
-
0346732026
-
Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans
-
DOI 10.1128/AAC.48.1.41-47.2004
-
Alem MA, Douglas LJ: Effect of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 2004; 48:41-47. (Pubitemid 38040174)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.1
, pp. 41-47
-
-
Alem, M.A.S.1
Douglas, L.J.2
-
28
-
-
0036775336
-
Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes
-
McLean KJ, Marshall KR, Richmond A, Hunter IS, Fowler K, Kieser T, et al: Azole antifungals are potent inhibitors of cyto-chrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomy-cetes. Microbiology 2002; 14 8: 2937-2949. (Pubitemid 35243693)
-
(2002)
Microbiology
, vol.148
, Issue.10
, pp. 2937-2949
-
-
McLean, K.J.1
Marshall, K.R.2
Richmond, A.3
Hunter, I.S.4
Fowler, K.5
Kieser, T.6
Gurcha, S.S.7
Besra, G.S.8
Munro, A.W.9
-
29
-
-
65649117884
-
Amiodarone and itraconazole: A rational therapeutic approach for the treatment of chronic chagas' disease
-
Paniz-Mondolfi AE, Pérez-Álvarez AM, Lanza G, Márquez E, Concepción JL: Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease. Chemotherapy 2009; 55:228-233.
-
(2009)
Chemotherapy
, vol.55
, pp. 228-233
-
-
Paniz-Mondolfi, A.E.1
Pérez-Álvarez, A.M.2
Lanza, G.3
Márquez, E.4
Concepción, J.L.5
-
30
-
-
0030667434
-
Integrating genetic approaches into the discovery of anticancer drugs
-
DOI 10.1126/science.278.5340.1064
-
Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH: Integrating genetic approaches into the discovery of anticancer drugs. Science 1997; 251:1064-1068. (Pubitemid 27517876)
-
(1997)
Science
, vol.278
, Issue.5340
, pp. 1064-1068
-
-
Hartwell, L.H.1
Szankasi, P.2
Roberts, C.J.3
Murray, A.W.4
Friend, S.H.5
-
31
-
-
0026470165
-
DNA topoisomerases from pathogenic fungi: Targets for the discovery of antifungal drugs
-
Shen LL, Baranowski J, Fostel J, Montgomery DA, Lartey PA: DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs. Antimicrob Agents Che-mother 1992; 36:2778-2784.
-
(1992)
Antimicrob Agents Che-mother
, vol.36
, pp. 2778-2784
-
-
Shen, L.L.1
Baranowski, J.2
Fostel, J.3
Montgomery, D.A.4
Lartey, P.A.5
-
32
-
-
0030069094
-
Bleomycin therapy of experimental disseminated candidiasis in mice
-
Graybill JR, Bocanegra R, Fothergill A, Ri-naldi MG: Bleomycin therapy of experimental disseminated candidiasis in mice. Anti-microb Agents Chemother 1996; 40:816-818. (Pubitemid 26071558)
-
(1996)
Antimicrobial Agents and Chemotherapy
, vol.40
, Issue.3
, pp. 816-818
-
-
Graybill, J.R.1
Bocanegra, R.2
Fothergill, A.3
Rinaldi, M.G.4
-
33
-
-
26844551665
-
Candidosis in children with onco-hematological diseases in Chennai, South India
-
Kumar CP, Sundarrajan T, Menon T, Ven-katadesikalu M: Candidiasis in children with onco-hematological diseases in Chen-nai, Sout h India. Jpn J Infect Dis 2005; 58: 218-221. (Pubitemid 41460926)
-
(2005)
Japanese Journal of Infectious Diseases
, vol.58
, Issue.4
, pp. 218-221
-
-
Kumar, C.P.G.1
Sundararajan, T.2
Menon, T.3
Venkatadesikalu, M.4
-
34
-
-
0036947856
-
Prospective evaluation of Candida species colonization in hospitalized cancer patient: Impact on short-term survival in recipients of marrow transplatation and patients with hematological malignancies
-
DOI 10.1038/sj.bmt.1703732
-
Safdar A, Armstrong D: Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematologi-cal malignancies. Bone Marrow Transplant 2002; 30:931-935. (Pubitemid 36097483)
-
(2002)
Bone Marrow Transplantation
, vol.30
, Issue.12
, pp. 931-935
-
-
Safdar, A.1
Armstrong, D.2
-
35
-
-
0034949280
-
Prospective study of Candida species in patients at a comprehensive cancer center
-
DOI 10.1128/AAC.45.7.2129-2133.2001
-
Safdar A, Chaturvedi V, Cross EW, Park S, Bernard EM, Armstrong D, et al: Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother 2001; 45:2129-2133. (Pubitemid 32591711)
-
(2001)
Antimicrobial Agents and Chemotherapy
, vol.45
, Issue.7
, pp. 2129-2133
-
-
Safdar, A.1
Chaturvedi, V.2
Cross, E.W.3
Park, S.4
Bernard, E.M.5
Armstrong, D.6
Perlin, D.S.7
-
36
-
-
0036025365
-
Resistance amongst yeast isolated from the oral cavities of patients with advanced cancer
-
DOI 10.1191/0269216302pm583oa
-
Davies A, Brailsford S, Broadley K, Beighton D: Resistance amongst yeasts isolated from the oral cavities of patients with advanced cancer. Palliat Med 2000; 16:527-531. (Pubitemid 35386012)
-
(2002)
Palliative Medicine
, vol.16
, Issue.6
, pp. 527-531
-
-
Davis, A.1
Brailsford, S.2
Broadley, K.3
Beighton, D.4
-
37
-
-
0034093263
-
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer
-
Chiou CC, Groll AH, Walsh TJ: New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 2000; 5:120-135. (Pubitemid 30238232)
-
(2000)
Oncologist
, vol.5
, Issue.2
, pp. 120-135
-
-
Chiou, C.C.1
Groll, A.H.2
Walsh, T.J.3
-
38
-
-
33846462456
-
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
-
DOI 10.1056/NEJMoa061094
-
Cornely OA, Maertens J, Winston DJ, Perfect J, Ulmann AJ, Walsh TJ, et al: Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-359. (Pubitemid 46148777)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.4
, pp. 348-359
-
-
Cornely, O.A.1
Maertens, J.2
Winston, D.J.3
Perfect, J.4
Ullmann, A.J.5
Walsh, T.J.6
Helfgott, D.7
Holowiecki, J.8
Stockelberg, D.9
Goh, Y.-T.10
Petrini, M.11
Hardalo, C.12
Suresh, R.13
Angulo-Gonzalez, D.14
-
39
-
-
0033972985
-
A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
-
DOI 10.1016/S0002-9343(99)00457-X, PII S000293439900457X
-
Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC: A multicenter, randomized trial of fluconazole versus ampho-tericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med 2000; 108:282-289. (Pubitemid 30110456)
-
(2000)
American Journal of Medicine
, vol.108
, Issue.4
, pp. 282-289
-
-
Winston, D.J.1
Hathorn, J.W.2
Schuster, M.G.3
Schiller, G.J.4
Territo, M.C.5
-
40
-
-
33845748649
-
Fluconazole for empiric antifun-gal therapy in cancer patients with fever neu-tropenia
-
Yu DT, Seger DL, Peterson JF, Kumar RN, Bates DW: Fluconazole for empiric antifun-gal therapy in cancer patients with fever neu-tropenia. BMC Infect Dis 2006; 6:1-10.
-
(2006)
BMC Infect Dis
, vol.6
, pp. 1-10
-
-
Yu, D.T.1
Seger, D.L.2
Peterson, J.F.3
Kumar, R.N.4
Bates, D.W.5
|